- Capital Cube•10 days ago
Click here to see latest analysisCapitalcube gives La Jolla Pharmaceutical Co. a score of 25.Our analysis is based on comparing La Jolla Pharmaceutical Co. with the following peers – Repligen Corporation, Vical Incorporated, Amgen Inc., Intercept Pharmaceuticals, Inc., Titan Pharmaceuticals, Inc., CEL-SCI Corporation and BioCryst Pharmaceuticals, Inc. (RGEN-US, VICL-US, AMGN-US, ICPT-US, TTNP-US, CVM-US and BCRX-US).Investment […] (Read more...) The post La Jolla Pharmaceutical Co. – Value Analysis (NASDAQ:LJPC) : July 18, 2016 appeared first on CapitalCube.
- Capital Cube•17 days agoLa Jolla Pharmaceutical Co. breached its 50 day moving average in a Bullish Manner : LJPC-US : July 11, 2016
Click here to see latest analysis*Disclaimer : This is as of previous day’s closing price.Technical IndicatorsBelow is a quick look at 5 technical indicators for La Jolla Pharmaceutical Co.. More studies are available on the Technical Chart.IndicatorSignalClosing Price above/below 50 Day Moving AverageBullishClosing Price above/below 200 Day Moving AverageBearish50 Day Moving Average above/below 200 Day […] (Read more...) The post La Jolla Pharmaceutical Co. breached its 50 day moving average in a Bullish Manner : LJPC-US : July 11, 2016 appeared first on CapitalCube.
La Jolla Pharmaceutical Co.NasdaqCM
After hours: 16.980.00 (0.00%) as of 4:55 PM EDT
|Bid||12.12 x 100|
|52wk Range||12.68 - 44.99|
|Day's Range||16.62 - 17.94|
|Avg Vol (3m)||145,900|
As of 4:00 PM EDT. Market closed.